Senolytics: Clearing 'Zombie Cells' and the Dasatinib-Quercetin Story
The cells aren't dead. That's actually the problem.
TL;DR
- Senolytics are compounds researchers study for their ability to clear senescent ("zombie") cells that linger and release inflammatory signals instead of dying normally.
- The most-studied combination, dasatinib plus quercetin, pairs a prescription cancer drug with a plant compound — and remains investigational for longevity use.
- This is an active area of human trials, not an approved therapy, and any dasatinib use requires physician supervision.
What it is
Senescent cells (cells that have stopped dividing but refuse to die, sometimes nicknamed "zombie cells") accumulate with age and release inflammatory molecules that can damage nearby healthy tissue. Senolytics are a class of compounds studied for their ability to selectively clear these lingering cells. The most researched combination pairs dasatinib, a prescription drug approved for certain blood cancers, with quercetin, a plant compound found in foods like onions and apples.
How it works
Picture a stalled car left in a busy intersection — it isn't going anywhere, but it blocks traffic and causes problems for everyone around it. A senescent cell works similarly: it survives past its useful life and pumps out inflammatory signals (researchers call this the senescence-associated secretory phenotype) that spread stress to nearby tissue. Senolytic compounds are studied for making these stalled cells more vulnerable to their own cell-death pathways — towing the stalled car out of the intersection (cellular senescence and senolytics, Kirkland & Tchkonia, EBioMedicine, 2019).
Who asks about it
People usually ask about this after encountering "zombie cells" or "senolytics" in longevity content and wanting to know whether this is an approved treatment they could access, or purely a research topic still moving through trials.
What the research says
Early-phase human trials of dasatinib plus quercetin have studied outcomes like physical function and inflammatory markers in small groups, with registered trials tracked publicly (dasatinib and quercetin senolytic trial, ClinicalTrials.gov, NCT02874989). Researchers describe results so far as early and promising rather than conclusive — a different evidence base than an FDA-approved indication, and the dosing studied for senescent-cell clearance differs from dasatinib's approved cancer-treatment use.
What to know before considering it
Dasatinib carries real side effects and drug interactions as a prescription oncology medication, and using it off-label for longevity purposes is a decision that belongs entirely with a physician who understands your full medical history. Quercetin supplements are widely available and generally well-tolerated, but the combination's long-term safety and effectiveness for aging specifically remains under active study, not settled.
The Halftime POV
Senolytics are exactly the kind of story we want readers to understand clearly before the marketing gets ahead of it: real biology, real early trials, and real distance between "promising research" and "proven therapy." Halftime Health does not currently offer senolytic protocols, and we think that distinction matters more than the hype cycle around it.
Related reading:
- The hallmarks of aging: how the field maps biological decline
- Longevity science: how to tell evidence from hype
- hs-CRP: the inflammation marker that predicts more than most tests
FAQ
Q: What are senolytics? A: Senolytics are compounds studied for their ability to selectively clear senescent cells — old cells that stop dividing but don't die, and instead release inflammatory signals into surrounding tissue.
Q: What is dasatinib and quercetin used for in longevity research? A: Dasatinib (a prescription cancer drug) and quercetin (a plant compound) are studied together in early human trials for their potential to clear senescent cells. This combination is not FDA-approved for longevity use.
Q: Are senolytics safe? A: Dasatinib is a prescription drug with known side effects and is only appropriately used under physician supervision for its studied purposes. Quercetin is generally well-tolerated, but the combination's long-term safety for longevity use is still being studied.
Q: Can you get a senolytic prescription for longevity purposes? A: Dasatinib is FDA-approved for certain cancers, not for longevity use, so a prescription for senescent-cell clearance would be off-label and requires a physician's judgment about individual risk and benefit.
Disclaimer
This article is educational and is not medical advice. Compounded medications are not FDA-approved. Clinical outcomes depend on individual factors and require physician evaluation. Results vary. Halftime Health is launching soon — join the waitlist to get updates.
Get updates
Halftime Health is launching soon. We'll share what we learn along the way — the research, the regulations, the real-world trade-offs. Join the waitlist and we'll email you when we're live.
Sources
- Kirkland JL, Tchkonia T. "Cellular Senescence: A Translational Perspective." EBioMedicine, 2019
- Dasatinib Plus Quercetin for Senescent Cell Clearance. ClinicalTrials.gov, NCT02874989
Frequently asked questions
What are senolytics?
Senolytics are compounds studied for their ability to selectively clear senescent cells — old cells that stop dividing but don't die, and instead release inflammatory signals into surrounding tissue.
What is dasatinib and quercetin used for in longevity research?
Dasatinib (a prescription cancer drug) and quercetin (a plant compound) are studied together in early human trials for their potential to clear senescent cells. This combination is not FDA-approved for longevity use.
Are senolytics safe?
Dasatinib is a prescription drug with known side effects and is only appropriately used under physician supervision for its studied purposes. Quercetin is generally well-tolerated, but the combination's long-term safety for longevity use is still being studied.
Can you get a senolytic prescription for longevity purposes?
Dasatinib is FDA-approved for certain cancers, not for longevity use, so a prescription for senescent-cell clearance would be off-label and requires a physician's judgment about individual risk and benefit.
Keep reading
A licensed physician can build a protocol from your own labs.
Membership from $69/mo, including your onboarding panel. Each protocol is its own monthly subscription.